(Q39430561)

11 September 2017

title

Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge (English)

1 reference

11 September 2017

1 reference

Georgitis JW

1

1 reference

11 September 2017

Meltzer EO

2

1 reference

11 September 2017

Kaliner M

3

1 reference

11 September 2017

Weiler J

4

1 reference

11 September 2017

Berkowitz R

5

1 reference

11 September 2017

publication date

1 April 2000

1 reference

Annals of Allergy, Asthma & Immunology

11 September 2017

published in

1 reference

11 September 2017

volume

84

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

451-459

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

11 September 2017

1 reference

7 January 2021

Pharmacologic management of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Inhibitory Effect of the H<sub>1</sub> Antagonist Loratadine on Histamine Release from Human Basophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Antiallergic activity of loratadine: inhibition of leukotriene C4 release from human leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM‐1 and HLA‐DR by nasal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

Efficacy of acrivastine in the treatment of allergic rhinitis during natural pollen exposure: onset of action

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962280-6

7 January 2021

10.1016/S1081-1206(10)62280-6

Identifiers

DOI

1 reference

11 September 2017

1 reference